InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong
· Delayed Price · Currency is HKD 65.90
+6.45 (10.85%)
Last updated: Mar 10, 2026, 3:03 PM HKT
HKG:3696 Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 212.63 | 125.94 | 177.18 | 207.88 |
| Cash & Short-Term Investments | 212.63 | 125.94 | 177.18 | 207.88 |
| Cash Growth | 2.28% | -28.92% | -14.77% | - |
| Accounts Receivable | 5.62 | 0.85 | 1.08 | 4.9 |
| Other Receivables | 4.47 | 3.84 | 3.83 | 1.43 |
| Receivables | 10.09 | 4.69 | 4.91 | 6.32 |
| Prepaid Expenses | 1.55 | 1.7 | 1.78 | 0.82 |
| Other Current Assets | 1.35 | 1.07 | 4.79 | 3.73 |
| Total Current Assets | 225.61 | 133.41 | 188.65 | 218.75 |
| Property, Plant & Equipment | 13.65 | 9.44 | 12.79 | 14.28 |
| Long-Term Investments | 0.67 | 0.25 | 0.41 | 1.03 |
| Other Intangible Assets | 0.27 | 0.27 | 0.38 | 0.19 |
| Other Long-Term Assets | 1.11 | 0.64 | 0.56 | 0.54 |
| Total Assets | 241.31 | 144 | 202.8 | 234.79 |
| Accounts Payable | 15.16 | 18.02 | 17.82 | 19.13 |
| Accrued Expenses | 6.97 | 12.79 | 11.64 | 7.02 |
| Current Portion of Leases | 2.18 | 1.5 | 1.27 | 1.38 |
| Current Income Taxes Payable | 0.18 | 0.23 | 0.23 | 0.29 |
| Current Unearned Revenue | 2.99 | 7.08 | 42.64 | 5.21 |
| Other Current Liabilities | 890.43 | 767.25 | 778.42 | 649.47 |
| Total Current Liabilities | 917.91 | 806.87 | 852.03 | 682.49 |
| Long-Term Leases | 4.77 | 1.06 | 0.93 | 1.84 |
| Total Liabilities | 922.68 | 807.93 | 852.95 | 684.33 |
| Additional Paid-In Capital | 0.63 | 0.62 | 0.21 | 0.21 |
| Retained Earnings | -699.77 | -680.56 | -663.46 | -451.82 |
| Treasury Stock | -2.05 | -2.05 | -11.35 | -11.35 |
| Comprehensive Income & Other | 19.82 | 18.06 | 24.44 | 13.42 |
| Shareholders' Equity | -681.36 | -663.92 | -650.16 | -449.54 |
| Total Liabilities & Equity | 241.31 | 144 | 202.8 | 234.79 |
| Total Debt | 6.95 | 2.56 | 2.19 | 3.22 |
| Net Cash (Debt) | 205.69 | 123.38 | 174.99 | 204.66 |
| Net Cash Growth | 0.50% | -29.49% | -14.50% | - |
| Net Cash Per Share | 2.68 | 1.72 | 2.59 | 3.05 |
| Filing Date Shares Outstanding | 77.27 | 77.24 | 67.57 | 67.06 |
| Total Common Shares Outstanding | 77.27 | 77.24 | 67.57 | 67.06 |
| Working Capital | -692.29 | -673.46 | -663.37 | -463.74 |
| Book Value Per Share | -8.82 | -8.60 | -9.62 | -6.70 |
| Tangible Book Value | -681.63 | -664.2 | -650.54 | -449.74 |
| Tangible Book Value Per Share | -8.82 | -8.60 | -9.63 | -6.71 |
| Machinery | 11.29 | 10.72 | 10.4 | 4.56 |
| Construction In Progress | 0.51 | 0.05 | 0.09 | 4.69 |
| Leasehold Improvements | 3.75 | 3.72 | 3.5 | 2.49 |
Source: S&P Capital IQ. Standard template. Financial Sources.